Create a Free Account
or
Create a Free Account
or
| # | Date | Analyst Firm | Upside/Downside | Price Target Change | Rating Change | Current Rating |
|---|
Cigna expects 2026–2027 margin pressure from its new rebate-free PBM model as major clients renew at lower margins, prompting a...
JP Morgan analyst John Stansel maintains Centene (NYSE:CNC) with a Neutral and raises the price target from $30 to $38.
Barclays analyst Andrew Mok maintains Centene (NYSE:CNC) with a Equal-Weight and raises the price target from $35 to $44.
TD Cowen analyst Ryan Langston maintains Centene (NYSE:CNC) with a Hold and raises the price target from $30 to $34.
Goldman Sachs analyst Scott Fidel maintains Centene (NYSE:CNC) with a Sell and raises the price target from $33 to $38.
Cantor Fitzgerald analyst Sarah James maintains Centene (NYSE:CNC) with a Neutral and raises the price target from $38 to $41.
Truist Securities analyst David Macdonald reiterates Centene (NYSE:CNC) with a Buy and raises the price target from $42 to $45.
A powerful surge in AI-related stocks — led by a 9% advance in NVIDIA Corp. (NASDAQ:NVDA) over the past two sessions — propelle...
